Clinical Trials Browser

OTHER × Carcinoma, Hepatocellular × Tyrosine Kinase Inhibitors × Clear all

NCT06632106 2024-10-08

HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC

Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06232759 2024-06-10

TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular